CLDX
Celldex Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$29.51
-0.37 ▼ -1.24%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$29.51
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.9 | Insider Own | 2.86% | Shs Outstand | 0.07B | Perf Week | 0.27% |
| Market Cap | 1.96B | Forward P/E | - | EPS next Y | 0.29% | Insider Trans | -2.73% | Shs Float | 0.06B | Perf Month | 19.96% |
| Enterprise Value | 1.45B | PEG | - | EPS next Q | -1.2 | Inst Own | 108.38% | Short Float | 13.93% | Perf Quarter | 4.68% |
| Income | -0.26B | P/S | 1267.34 | EPS this Y | -23.89% | Inst Trans | 4.44% | Short Ratio | 11.11 | Perf Half Y | 17.1% |
| Sales | 0.00B | P/B | 3.73 | EPS next 5Y | 2.37% | ROA | -37.63% | Short Interest | 9.01M | Perf YTD | 8.65% |
| Book/sh | 7.92 | P/C | 3.82 | EPS past 3/5Y | -17.59% -14.07% | ROE | -40.62% | 52W High | -7.75% ($31.99) | Perf Year | 46.52% |
| Cash/sh | 7.72 | P/FCF | - | Sales past 3/5Y | -13.13% -26.93% | ROIC | -49.01% | 52W Low | 104.93% ($14.40) | Perf 3Y | -31.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -59.3% | Gross Margin | -118.63% | Volatility(W/M) | 5.51% 5.7% | Perf 5Y | 16.27% |
| Dividend TTM | - | EV/Sales | 937.12 | Sales Y/Y TTM | -77.98% | Oper. Margin | -18587.71% | ATR (14) | 1.52 | Perf 10Y | -43.47% |
| Dividend Ex-Date | - | Quick Ratio | 10.49 | EPS Q/Q | -72.33% | Profit Margin | -16737.19% | RSI (14) | 58.06 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.49 | Sales Q/Q | -89.7% | SMA20 | 6.15% ($27.8) | Beta | 1.25 | Target Price | $55.07 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 11.54% ($26.46) | Rel Volume | 0.63 | Prev Close | $29.88 |
| Employees | 198 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -19.35% -92.4% | SMA200 | 19.63% ($24.67) | Avg Volume(3M) | 0.81M | Price | $29.51 |
| IPO | 1986/5/15 | Option/Short | Yes/Yes | Trades | 8558 | Volume | 510,034 | Change | -1.24% |
뉴스 로딩 중...